Blue Earth Diagnostics: Clinical Trials

7 trials sponsored by Blue Earth Diagnostics, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 recruiting, 2 completed, 1 terminated. 7 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 17Recruiting 4, Completed 2, Terminated 1
Phase 22Recruiting 1, Terminated 1

Follow Blue Earth Diagnostics: new trials by email

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications
[18F]FPyQCP - Colorectal Cancer, Epithelial Ovarian Cancer
Phase 1 / Phase 2RecruitingBlue Earth Diagnostics712026-02-192026-10-28
18F-Fluciclovine PET Amino Acid Evaluation of Brain Metastasis Treated With Stereotactic Radiosurgery
18F fluciclovine - Brain Metastases, Brain Metastases, Adult
Phase 1RecruitingBaptist Health South Florida462024-04-112026-05-20
Pilot Study for Detection of PSMA-Low CRPC-NE Tumors With Fluciclovine PET/CT
18F-fluciclovine, PET/CT - Advanced Prostate Cancer, Metastatic Prostate Cancer
Phase 1RecruitingBrigham and Women's Hospital302024-02-012026-10-29
Assess Use of 18F-Fluciclovine for Patients With Large Brain Metastases Treated With Staged Stereotactic Radiosurgery
18F fluciclovine - Brain Metastases, Adult, Brain Metastases
Phase 1RecruitingBaptist Health South Florida202022-04-042026-04-22
[18F]Fluciclovine in Post-treatment Glioblastoma ( Axumin )
Axumin, Intravenous Solution - Glioma Glioblastoma Multiforme
Phase 1CompletedAli Nabavizadeh302019-06-122021-12-22
Assessing Radio-hybrid Prostate Specific Membrane Antigen (rhPSMA-7.3) (18F) in Healthy Volunteers and Subjects With Prostate Cancer
rhPSMA-7.3 (18F) Injection - Prostate Cancer
Phase 1CompletedBlue Earth Diagnostics242019-06-112026-02-12
[18F]Fluciclovine and [18F]FLT PET/CT Assessment of Primary High-Grade Brain Tumors
[18F]FLT, [18F]Fluciclovine - Brain Tumor
Phase 1 / Phase 2TerminatedUniversity of Utah102018-09-242024-12-27

Conditions studied

Brain Neoplasms (3)  ·  Prostatic Neoplasms (2)  ·  Carcinoma, Lobular (1)  ·  Carcinoma, Ovarian Epithelial (1)  ·  Colorectal Neoplasms (1)  ·  Glioblastoma (1)  ·  Stomach Neoplasms (1)

Interventions

fluciclovine F-18 (5)  ·  Injections (1)  ·  Positron Emission Tomography Computed Tomography (1)  ·  alovudine (1)

Countries

United States (6)  ·  Finland (1)

Top investigators

Heather Jacene, MD (1)  ·  Jeffrey Yap, PhD (1)  ·  Mika Scheinin (1)  ·  Rupesh Kotecha, M.D. (1)  ·  Rupesh R Kotecha, MD (1)  ·  Steven Rowe, MD (1)

Results publications

PMID 34081125, PMID 33846844